This strategy meeting will cover the key topics that are the drivers behind the issues that we face. Learn what industry leaders are doing in their business, collaborate with your competitors, debate with your peers and start building your cross industry team.
Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer’s overall market access strategy
Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
Examine how to use HTA to create payer evidence: The role of post-approval programs
Analyze the current state of affairs: Post midterm elections in the exchange marketplace and the impact on drug positioning
Stacie Maass - Senior Vice President, Pharmacy Practice and Government Affairs, American Pharmacist Association
Vivian Coates - Senior Vice President, Information Services and Health Technology Assessment ECRI Institute
Oved Amitay - VP, Head of Commercial, Alnylam Pharmaceuticals
...and many others!
Who should attend:
This strategy session was designed by an advisory board of leading experts in the: pharmaceutical, biotechnology, specialty pharma, generics, medical devices, and life science industries. Who should attend:
Phone number: +1 312 582 4273
740 North Rush Street, Suite 100
American Leaders: A subsidiary of Fleming Group, American Leaders organizes Five-Star events which present unbiased data and professional insights from various organizations targeting multiple industries.